Sunshine Biopharma Inc. (NASDAQ:SBFM) Financings

Sunshine Biopharma Inc.

Financings

RaiseDate
Public offering of common Units (or Pre-Funded Units)
Closed: US$6M raised · US$0.55 a unit · Warrants at US$0.66 for 60 months · Aegis Capital Corp.
Dealers: Aegis Capital Corp. (lead)
Use of proceeds: General corporate purposes and working capital
Oct 9, 2026
Registered direct offering of shares of Common Stock and pre-funded warrants
Closed: US$2.46M raised · US$2.07 a share · Aegis Capital Corp.
Dealers: Aegis Capital Corp. (lead)
Use of proceeds: General corporate purposes and working capital
Apr 3, 2025

Read by 6ix AI from the company's releases